Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis
Open accessThe DOI matches its Crossref record; 24 of the 26 references it cites were found in a registry or an index.
Abstract
Objective To examine endocrine and clinical responses to long-term administration of RU486 in patients with endometriosis. Design Prospective open trial. Setting Faculty practice of the authors. Patients, participants Six normally cycling women with endometriosis were recruited. Interventions Subjects received RU486 100 mg/d for 3 months. Main outcome measure(s) Hormonal changes during RU486 were compared with control data obtained in the preceding cycle during the early follicular phase. Clinical responses were determined by patient assessment and second-look laparoscopy. Results All women became amenorrheic, and daily urinary levels of ovarian steroid metabolites remained acyclic. Mean luteinizing hormone (LH) (P less than 0.02) and LH pulse amplitude (P less than 0.05) were increased without changes in LH pulse frequency. An antiglucocorticoid effect was demonstrated by an increase in serum cortisol (P less than 0.01) and adrenocorticotropic hormone (P less than 0.05) levels. Treatment resulted in an improvement in pelvic pain in all subjects without significant change in the extent of disease as evaluated by follow-up laparoscopy. Conclusions Daily administration of RU486 results in acyclic ovarian function and improvement in the subjective painful symptoms of endometriosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mifepristone-induced regression of endometriotic lesions has been variable and appears to be dependent on the duration of treatment [265, 266].”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [265]
In the citing paper
“A small prospective open-label trial suggested the possible efficacy of mifepristone for endometriosis-associated pain [265].”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [265]
Citations
Cites
Revised American Fertility Society Classification of Endometriosis: 1985
(1985) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48430-x · Cited by 1,803
Contragestion and Other Clinical Applications of RU 486, an Antiprogesterone at the Receptor
Baulieu, E.-E. (1989) · Science · doi:10.1126/science.2781282 · Cited by 483
The Antiprogestin Steroid RU 486 and Human Fertility Control
(1985) · Springer eBooks · doi:10.1007/978-1-4684-1242-0 · Cited by 298
The New Steroid Analog RU 486 Inhibits Glucocorticoid Action in Man
BERTAGNA, X., BERTAGNA, C., LUTON, J.-P., HUSSON, J.-M., & GIRARD, F. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-1-25 · Cited by 235
Endometrial and Pituitary Responses to the Steroidal Antiprogestin RU 486in Postmenopausal Women
GRAVANIS, A., SCHAISON, G., GEORGE, M., DE BRUX, J., SATYASWAROOP, P. G., BAULIEU, E. E., & ROBEL, P. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-1-156 · Cited by 189
Lessey, B. A., Metzger, D. A., Haney, A. F., & McCarty, K. S. (1989) · Fertility and Sterility · doi:10.1016/s0015-0282(16)60545-9 · Cited by 176
LIU, J. H., GARZO, G., MORRIS, S., STUENKEL, C., ULMANN, A., & YEN, S. S. C. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-6-1135 · Cited by 157
Self-citationAntiprogestins, a new form of endocrine therapy for human breast cancer.
Klijn, J. G. M., Jong, F. H. D., Bakker, G. H., Lamberts, S. W. J., Rodenburg, C. J., & Alexieva-Figusch, J. (1989) · PubMed · Cited by 141
Effects of the Antiprogesterone Steroid RU 486 during Midluteal Phase in Normal Women
SCHAISON, G., George, M. J., Lestrat, N., Reinberg, A., & Baulieu, E. E. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-3-484 · Cited by 136
Blockade by Progesterone of Estrogen—Induced LH and FSH Release in the Rhesus Monkey12
Dierschke, D. J., YAMAJI, T., Karsch, F. J., Weick, R. F., Weiss, G., & Knobil, E. (1973) · Endocrinology · doi:10.1210/endo-92-5-1496 · Cited by 130
March, C. M., Goebelsmann, U., Nakamura, R. M., & Mishell, D. R. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-49-4-507 · Cited by 126
Wolf, J. P., Hsiu, J. G., Anderson, T. L., Ulmann, A., Baulieu, E. E., & Hodgen, G. D. (1989) · Fertility and Sterility · doi:10.1016/s0015-0282(16)53174-4 · Cited by 112
Self-citationCOLLINS, R. L., & HODGEN, G. D. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-6-1270 · Cited by 104
The antiprogestin RU486 in advanced breast cancer: preliminary clinical trial.
Romieu, G., Maudelondé, T., Ulmann, A., Pujol, H., Grenier, J., Cavalie, G., Khalaf, S., & Rochefort, H. (1987) · PubMed · Cited by 98
Self-citationInhibition of folliculogenesis and ovulation by the antiprogesterone RU 486
Luukkainen, T., Heikinheimo, O., Haukkamaa, M., & Lähteenmäki, P. (1988) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59944-0 · Cited by 95
Garzo, V. G., LIU, J. H., Ulmann, A., Baulieu, E. E., & Yen, S. S. C. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-3-508 · Cited by 83
Self-citationA novel general biophysical model for simulating episodic endocrine gland signaling
Veldhuis, J. D., & Johnson, M. L. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.255.6.e749 · Cited by 81
Neulen, J., Williams, R. F., & Hodgen, G. D. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-4-1074 · Cited by 50
The antiprogestin RU486 in advanced breast cancer: Preliminary clinical trial
Romieu, G., Maudelondé, T., & Ulmann, A. (1988) · Maturitas · doi:10.1016/0378-5122(88)90165-x · Cited by 35
Self-citationPharmacodynamics of the antiprogesterone RU486 in women after oral administration
LIU, J. H., Garzo, V. G., & Yen, S. S. C. (1988) · Fertility and Sterility · doi:10.1016/s0015-0282(16)60067-5 · Cited by 34
Self-citationKekkonen, R., Alfthan, H. V., Haukkamaa, M., Heikinheimo, O., Luukkainen, T., & Lähteenmäki, P. (1990) · Fertility and Sterility · doi:10.1016/s0015-0282(16)53478-5 · Cited by 32
Effects of the antiprogesterone RU486 in the early follicular phase of the menstrual cycle
Stuenkel, C. A., Garzo, V. G., Morris, S., LIU, J. H., & Yen, S. S. C. (1990) · Fertility and Sterility · doi:10.1016/s0015-0282(16)53457-8 · Cited by 18
Self-citationRoseff, S., Kettel, L. M., Rivier, J., Burger, H., Baulieu, E. E., & Yen, S. S. C. (1990) · Fertility and Sterility · doi:10.1016/s0015-0282(16)53936-3 · Cited by 17
Self-citationRU 486: Studies of Its Antiglucocorticosteroid Activity in Man
Gaillard, R.-C., Riondel, A. M., Muller, A. F., HERRMANN, W. L., & Baulieu, E. E. (1985) · Springer eBooks · doi:10.1007/978-1-4684-1242-0_30 · Cited by 8
Cited by
Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens
McDonnell, D. P. (1995) · Molecular Endocrinology · doi:10.1210/me.9.6.659 · Cited by 526
Wen, D. X., Xu, Y. F., Mais, D. E., Goldman, M. E., & McDonnell, D. P. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8356 · Cited by 355
“In view of these data, it is now unclear to what extent the clinical efficacy of RU486 in the treatment of endometriosis, uterine fibroids, brain meningiomas, and hormone-dependent breast cancers results from its ability to function as an antiprogestin or an antiestrogen (1, 11, 22, 30).”
BackgroundHormonal treatments for endometriosis: The endocrine background
Vannuccini, S., Clemenza, S., Rossi, M., & Petraglia, F. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09666-w · Cited by 336
An overview of spirooxindole as a promising scaffold for novel drug discovery
Zhou, L.-M., Qu, R.-Y., & Yang, G.-F. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1733526 · Cited by 316
“Therefore, this type of cyclohexyl compound has potential utility as contraceptive or medicine used in the treatment of reproductive disorders (such as endometriosis, uterine leiomyomas, and hormone-dependent tumors) [199,198].”
BackgroundAn open label trial of C-1073 (mifepristone) for psychotic major depression*
Belanoff, J. K., Rothschild, A. J., Cassidy, F., DeBattista, C., Baulieu, E.-E., Schold, C., & Schatzberg, A. F. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01432-4 · Cited by 320
Metadata
- Authors
- Kettel, L. M., Murphy, A. A., Mortola, J. F., Liu, J. H., Ulmann, A., & Yen, S. S. C.
- Affiliations
- University of California San Diego (US)
- ORCID
- Liu, James H.
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 1991-09
- Volume
- 56
- Issue
- 3
- Pages
- 402-407
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W1463735117
- Cited by
- 151
- References
- 26
- Citations by year
- 2024: 1 · 2021: 4 · 2020: 4 · 2018: 3 · 2017: 1 · 2016: 1 · 2015: 3 · 2014: 5 · 2013: 3 · 2012: 5
- FWCI
- 11.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 11226 d)
- Locations
- Fertility and Sterility (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Keywords
- RU486, mifepristone, pelvic endometriosis, endocrine effects, luteinizing hormone, LH pulse amplitude, amenorrhea, cortisol, ACTH, pelvic pain, second-look laparoscopy
- MeSH terms
- Adolescent, Adrenocorticotropic Hormone, Adult, Amenorrhea, Endocrine Glands, Endometriosis, Female, Hormones, Humans, Hydrocortisone, Palliative Care, Pelvic Neoplasms, Laparoscopy, Progesterone, Time Factors, Mifepristone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.